CAS: 38194-50-2 - Sulindac
Formula:C20H17FO3S
InChI:InChI=1/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-
InChI key:InChIKey=MLKXDPUZXIRXEP-MFOYZWKCNA-N
SMILES:O=C(O)CC=1C=2C=C(F)C=CC2C(=CC3=CC=C(C=C3)S(=O)C)C1C
- Synonyms:
- (1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid
- (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
- (Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid
- 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, (Z)-
- 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-
- 5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid
- Aflodac
- Algocetil
- Arthrocine
- Artribid
- See more synonyms
- Brn 2951842
- Ccris 3305
- Citireuma
- Clinoril
- Clisundac
- Imbaral
- Mk 231
- Mobilin
- Reumofil
- Reumyl
- Sudac
- Sulindac sulfoxide
- Sulindaco
- Sulindacum
- Sulinol
- Sulreuma
- Unii-184Sns8Vuh
- cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
- cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid
- cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidenyl)indene-3-acetic acid
- cis-Sulindac
- {(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid
- {5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid
Sulindac
CAS:38194-50-2
Formula:
C20H17FO3S
Purity:
>98.0%(T)(HPLC)
Color and Shape:
Light yellow to Brown powder to crystal
Molecular weight:
356.41
- Anti-inflammatory
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Enzyme Activators and Inhibitors
- Enzymes
- See more categories
- Immunology and Inflammation
- Cyclooxygenase (COX) Inhibitors
- Active Pharmaceutical Ingredient (API) Related Compounds for Research
- Biochemicals and Reagents
- Cellular and Molecular Biology
Ref: 3B-U0099
10g | 130.00 € | ||
50g | 397.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024
Ref: 41-Y0002255
15mg | 115.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Ref: 47-1041
50mg | 211.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Ref: 41-S2180000
100mg | 115.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Sulindac
CAS:38194-50-2
Other aromatic organo-sulfur compounds (excluding pesti
Formula:
C20H17FO3S
Color and Shape:
Yellow Orange Powder
Molecular weight:
356.08824
Estimated delivery in United States, on Wednesday 4 Dec 2024
Sulindac
CAS:38194-50-2
Sulindac (Sulindac sulfoxide) is a sulfinylindene derivative prodrug with potential antineoplastic activity.
Formula:
C20H17FO3S
Purity:
99.32% - 99.49%
Color and Shape:
Yellow Solid
Molecular weight:
356.41
Ref: TM-T0459
50mg | 52.00 € | ||
100mg | 56.00 € | ||
200mg | 76.00 € | ||
500mg | 94.00 € | ||
1mL*10mM (DMSO) | 55.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ref: 4Z-S-291
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-S-297
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 7W-GP2027
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Sulindac
Controlled ProductCAS:38194-50-2
Formula:
C20H17FO3S
Color and Shape:
Neat
Molecular weight:
356.41
Ref: 86-MM0624.00
500mg | 153.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Sulindac 100 µg/mL in Acetonitrile
CAS:38194-50-2
Formula:
C20H17FO3S
Color and Shape:
Single Solution
Molecular weight:
356.41
Ref: 04-A17025500AL-100
1ml | 79.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Sulindac
Controlled ProductCAS:38194-50-2
Formula:
C20H17FO3S
Color and Shape:
Neat
Molecular weight:
356.41
Ref: 04-C17025500
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
(Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid
CAS:38194-50-2
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
356.4100036621094
Ref: 10-F219743
1g | To inquire | ||
5g | To inquire | ||
25g | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Sulindac
Controlled ProductCAS:38194-50-2
Applications Sulindac is a non-steroidal anti-inflammatory drug. Not a dangerous good if item is equal …
Formula:
C20H17FO3S
Color and Shape:
Yellow To Dark Orange
Molecular weight:
356.41
Ref: TR-S699215
1g | 105.00 € | ||
5g | 130.00 € | ||
50mg | 87.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Sulindac
CAS:38194-50-2
COX inhibitor; nonsteroidal anti-inflammatory drug
Formula:
C20H17FO3S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
356.41 g/mol
Ref: 3D-FS27969
2g | 180.00 € | ||
5g | 260.00 € | ||
10g | 366.00 € | ||
25g | 588.00 € | ||
50g | 861.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Sulindac - Bio-X ™
CAS:38194-50-2
Sulindac is a non-steroidal anti-inflammatory drug that has anti-inflammatory and analgesic properties. It is used …
Formula:
C20H17FO3S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
356.41 g/mol
Ref: 3D-BS166205
100mg | 137.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
1H-Indene-3-aceticacid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-
CAS:38194-50-2
Formula:
C20H17FO3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
356.4106
- Anti-inflammatory
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Enzyme Activators and Inhibitors
- Active Pharmaceutical Ingredients (API) for research
- See more categories
- Enzymes
- Immunology and Inflammation
- Cyclooxygenase (COX) Inhibitors
- Active Pharmaceutical Ingredient (API) Related Compounds for Research
- Biochemicals and Reagents
- Cellular and Molecular Biology
Ref: IN-DA007B4T
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
25g | Discontinued | Request information |